News and Events
Study uncovers mechanism behind effectiveness of three-drug combination in patients with a rare bile duct cancer
Combining anti-VEGF therapy with immune checkpoint inhibitors stimulated the production of B cells to fight cholangiocarcinoma, a rare bile duct cancer.
Read MorePast, Present, and Future of Cellular Immunotherapy: Scientific Symposium Celebrating Steven A. Rosenberg's 50 years at NCI
Date: September 26-27, 2024
Location: Masur Auditorium, Building 10
The symposium will discuss the development of cell therapy for the treatment of human cancer, from early studies from the Center for Cancer Research's Surgery Branch to current clinical and translational research being performed around the world. Sessions will focus on the initial development of cell therapy for patients with metastatic melanoma, the introduction of gene engineering into cell therapy, and the use of cell therapy to address common epithelial cancers.
Read More2024 NCI RNA Biology Initiative Workshop
Date: April 23, 2024
Location: NCI Shady Grove
The NCI RNA Biology Initiative aims to create an inter-disciplinary environment to facilitate the rapid exchange of information and expertise on the structure, function, and biological roles of RNA and to foster synergistic interactions amongst NCI investigators. We anticipate that insights into RNA biology and the development of RNA-based tools will define novel targets and accelerate the implementation of therapeutic interventions in cancer.
This one-day workshop will include internal and external speakers with expertise in the topic area. The aim is to foster interaction among major laboratories in the areas of RNA Biology and to enhance the education and development of junior investigators and fellows in NCI laboratories.
Read MoreGene therapy proves successful in children with Wiskott-Aldrich syndrome
Wiskott-Aldrich syndrome (WAS) is a rare genetic disorder where males lack a gene critical for healthy blood and immune cell functioning. In a recent clinical trial, gene therapy for WAS was found to improve patients’ symptoms — an effect that was sustained for many years afterward.
Read MoreSteven Rosenberg receives the National Medal of Technology and Innovation
On October 24, 2023, President Biden awarded Steven A. Rosenberg, M.D., Ph.D., Chief of the Surgery Branch, the National Medal of Technology and Innovation for pioneering the development of immunotherapy. The award is the nation’s highest honor for technological achievement, bestowed by the president of the United States on America's leading innovators.
Read MoreClinical trial researches therapy for squamous cell carcinomas
Vassiliki Saloura, M.D., Ph.D., Stadtman Investigator in the Thoracic and GI Malignancies Branch, is leading CCR participation in a trial to research photoimmunotherapy with imaging for adults with head and neck or cutaneous squamous cell carcinoma.
Read MoreNew CAR T-cell therapy eliminates rhabdomyosarcoma in mice
After seeing excellent results of a CAR T-cell therapy against rhabdomyosarcoma in mice, a team of CCR researchers is preparing to test the immunotherapy in humans.
Read MoreCCR Hosts “Frontiers in Basic Immunology” Symposium
CCR hosted a two-day international symposium, titled “Frontiers in Basic Immunology,” sponsored by the NCI Center of Excellence in Immunology (CEI). The program included a lineup of presentations from NCI and worldwide academic university speakers and a lively poster session.
Read MoreClinical trial researches radiation therapy for prostate tumors
A clinical trial led by Krishnan R. Patel, M.D., Assistant Research Physician in the Radiation Oncology Branch, is researching radiation therapy for prostate cancer.
Read MoreThe ups and downs of a rare blood cancer won’t stop one resilient patient
Even with a rare cancer diagnosis and a roller-coaster ride of a journey, Luis Miguel Cruz continues to find the motivation to keep moving forward through every setback. Along the way, he has inspired and brought joy to those he has met, both in person and digitally.
Read MoreClinical trial researches targeted therapy for biliary tract cancers
A clinical trial led by Jonathan M. Hernandez, M.D., Investigator in the Surgical Oncology Program, is researching targeted therapy for cholangiocarcinoma and gallbladder cancer.
Read More